- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Diagnostic Kits
Radient Pharmaceuticals Corp
+ Add to WatchlistRXPC:US
0.0002 USD 0.0001 100.00%As of 20:10:00 ET on 05/17/2013.
Snapshot for Radient Pharmaceuticals Corp (RXPC)
| Open: | 0.0002 | Day's Range: | 0.0002 - 0.0002 | Volume: | 650,444 |
|---|---|---|---|---|---|
| Previous Close: | 0.0001 | 52wk Range: | 0.0001 - 0.0180 | 1-Yr Rtn: | -98.89% |
Key Statistics for RXPC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -12.2500 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.27 |
| Shares Outstanding (M) | 1,347.94 |
| 30 Day Average Volume | 29,089,512 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 0.0042 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RXPC
No data available
Company Profile & Key Executives for RXPC
Radient Pharmaceuticals Corp. researches, develops, manufactures, and markets in vitro diagnostic (IVD) and skin care products.
| Douglas C MaclellanChairman/President/CEO | Akio AriuraCFO/COO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
RXPC News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page